Camp4 Therapeutics GAAP EPS of -$2.65 misses by $0.77, revenue of $3.5M in-line

Camp4 Therapeutics (CAMP) earnings: GAAP EPS -$2.65 miss, revenue $3.5M up 438% YoY; cash $109.5M funds plans into 2028.

Read Full Article →